Ophthalmic startup EyeYon Medical announced today the completion of a $25 million in a Series C funding.
The round was led by CR-CP Life Science Fund, which invests in life science companies that develop drugs, cell therapies, medical devices, and smart healthcare technology.
Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and...
